✦ LIBER ✦

Postmastectomy lymphangiosarcoma-temporary response to cyclophosphamide chemotherapy in 2 cases

✍ Scribed by David Tong; John Winter

Publisher: John Wiley and Sons
Year: 1974
Tongue: English
Weight: 620 KB
Volume: 61
Category: Article
ISSN: 0007-1323
DOI: 10.1002/bjs.1800610118

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Correlation between HER-2 expression and

Correlation between HER-2 expression and response to neoadjuvant chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide in patients with breast carcinoma

✍ Fan Zhang; Ying Yang; Terry Smith; Shu-Wan Kau; Judy M. McConathy; Francisco J. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

## Abstract ## BACKGROUND The objective of this study was to determine whether HER‐2 overexpression is associated with improved response to neoadjuvant chemotherapy with 5‐fluorouracil, doxorubicin, cyclophosphamide (FAC) in patients with breast carcinoma. ## METHODS Ninety‐seven patients with S

ErbB2 overexpression in human breast car

ErbB2 overexpression in human breast carcinoma is correlated with p21Cip1 up-regulation and tyrosine-15 hyperphosphorylation of p34Cdc2 : Poor responsiveness to chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil is associated with ErbB2 overexpression and with p21Cip1 overexpression

✍ Wentao Yang; Kristine S. Klos; Xiaoyan Zhou; Jun Yao; Ying Yang; Terry L. Smith; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 753 KB

## Abstract ## BACKGROUND Clinical investigations have shown that in patients with breast carcinoma, tumors that overexpress the __erb__‐B2 gene are less responsive to certain chemotherapy regimens compared with tumors that express low levels of __ErbB2__, suggesting that ErbB2 overexpression may

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views